Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessment of the Anti-inflammatory Effects of Norflo Oro in Acute Relapses of HLA-B27 Associated Autoimmune Uveitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03584724
Recruitment Status : Active, not recruiting
First Posted : July 12, 2018
Last Update Posted : July 10, 2019
Sponsor:
Collaborator:
Bascom Palmer Eye Institute
Information provided by (Responsible Party):
Eye Pharma